<p>The amount of TNFα, IL-6 and MCP1 was measured by ELISA from the whole blood plasma collected after 18 h of LPS (100 pg/ml) treatment (n = 4). Data is presented as mean ± S.E. *p<0.05.</p
Mφ (n = 6) were pre-treated with either 25(OH)D3 (100 nM and 500 nM) or 1.25(OH)2D3 (0.05 nM and 10 ...
<p>(<b>A</b>–<b>D</b>) Male C57BL/6 mice at 6 weeks of age were given LPS (400 µg/head i.p.), and bl...
<p>SIVmac239-infected animals were intravenously injected with a single dose of LPS (50 µg/kg, solid...
<p>* <i>vs.</i> unstimulated control (0 ng/mL LPS); § <i>vs.</i> 0.1 ng/mL LPS; † <i>vs.</i> 1 ng/mL...
<p><b>A</b>. IL-6 release was determined by ELISA in culture supernatants harvested 3 h, 6 h and 24 ...
<p>(A–B) The plasma levels of TNF-α and IL-6 were determined using commercial ELISA kits, <i>n</i> =...
<p>Cells were exposed to LPS (1–100 ng/ml) in the presence and absence of serum for 24 hours. Condit...
<p>Blood samples were collected retro-bulbar from <i>Mrp4<sup>−/−</sup></i> mice (open bars) and <i>...
<p>IL-6, IL-8 and MCP-1 protein levels in the plasma were measured by ELISA, (A) IL-6 and (B) IL-8 a...
<p>Cells were pre-treated with 10 mM GSH-C4 or NAC for 2 h, washed and then LPS was added for 24 h. ...
<p>IL-1β (a), TNF-α (b), IL-6 (c), IL-1ra (d), corticosterone (e) and PGEM (f) as measured by ELISA ...
<p>Vehicle and acute LPS (150 µg/Kg) treatments were performed and maternal plasma was extracted: 4 ...
<p>Chronic LPS (5 µg/Kg) treatment was performed daily from E11.5 until E15.5. (A) Maternal plasma w...
<p>Challenge with LPS causes a marked increase in IL-6 levels, which are partly prevented by pre-inc...
<p>THP-1 were treated with 0, 5, 10 and 25 ng/mL PMA for 48h prior exposure to 1 μg/mL LPS. The conc...
Mφ (n = 6) were pre-treated with either 25(OH)D3 (100 nM and 500 nM) or 1.25(OH)2D3 (0.05 nM and 10 ...
<p>(<b>A</b>–<b>D</b>) Male C57BL/6 mice at 6 weeks of age were given LPS (400 µg/head i.p.), and bl...
<p>SIVmac239-infected animals were intravenously injected with a single dose of LPS (50 µg/kg, solid...
<p>* <i>vs.</i> unstimulated control (0 ng/mL LPS); § <i>vs.</i> 0.1 ng/mL LPS; † <i>vs.</i> 1 ng/mL...
<p><b>A</b>. IL-6 release was determined by ELISA in culture supernatants harvested 3 h, 6 h and 24 ...
<p>(A–B) The plasma levels of TNF-α and IL-6 were determined using commercial ELISA kits, <i>n</i> =...
<p>Cells were exposed to LPS (1–100 ng/ml) in the presence and absence of serum for 24 hours. Condit...
<p>Blood samples were collected retro-bulbar from <i>Mrp4<sup>−/−</sup></i> mice (open bars) and <i>...
<p>IL-6, IL-8 and MCP-1 protein levels in the plasma were measured by ELISA, (A) IL-6 and (B) IL-8 a...
<p>Cells were pre-treated with 10 mM GSH-C4 or NAC for 2 h, washed and then LPS was added for 24 h. ...
<p>IL-1β (a), TNF-α (b), IL-6 (c), IL-1ra (d), corticosterone (e) and PGEM (f) as measured by ELISA ...
<p>Vehicle and acute LPS (150 µg/Kg) treatments were performed and maternal plasma was extracted: 4 ...
<p>Chronic LPS (5 µg/Kg) treatment was performed daily from E11.5 until E15.5. (A) Maternal plasma w...
<p>Challenge with LPS causes a marked increase in IL-6 levels, which are partly prevented by pre-inc...
<p>THP-1 were treated with 0, 5, 10 and 25 ng/mL PMA for 48h prior exposure to 1 μg/mL LPS. The conc...
Mφ (n = 6) were pre-treated with either 25(OH)D3 (100 nM and 500 nM) or 1.25(OH)2D3 (0.05 nM and 10 ...
<p>(<b>A</b>–<b>D</b>) Male C57BL/6 mice at 6 weeks of age were given LPS (400 µg/head i.p.), and bl...
<p>SIVmac239-infected animals were intravenously injected with a single dose of LPS (50 µg/kg, solid...
DOI
Add to ORKG